Titan Medical Inc. (TMDIF)
OTCMKTS: TMDIF · Delayed Price · USD
0.0515
+0.0005 (0.98%)
Mar 28, 2024, 3:52 PM EDT - Market closed

Titan Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Revenue
20.0920000
Revenue Growth (YoY)
0.47%----
Gross Profit
20.0920000
Selling, General & Admin
12.437.637.823.333.01
Research & Development
37.967.9451.4232.8612.9
Other Operating Expenses
0.70.280.033.512.97
Operating Expenses
51.0815.8559.2739.6918.88
Operating Income
-30.994.15-59.27-39.69-18.88
Interest Expense / Income
0.131.090.42-0.29-0.02
Other Expense / Income
-16.3127.24-17.78-16.7614.72
Pretax Income
-14.8-24.18-41.91-22.64-33.59
Income Tax
0.060000
Net Income
-14.86-24.18-41.91-22.64-33.59
Shares Outstanding (Basic)
1116731178
Shares Outstanding (Diluted)
-6731178
Shares Change
65.84%118.34%84.49%110.59%-
EPS (Basic)
-0.14-0.36-1.37-1.36-4.25
EPS (Diluted)
-0.14-0.36-1.37-1.36-4.25
Free Cash Flow
-36.99-1.13-45.96-41.4-19.09
Free Cash Flow Per Share
-0.33-0.02-1.50-2.49-2.42
Gross Margin
100.00%100.00%---
Operating Margin
-154.22%20.76%---
Profit Margin
-73.95%-120.92%---
Free Cash Flow Margin
-184.08%-5.63%---
EBITDA
-13.98-22.81-41.45-22.9-33.59
EBITDA Margin
-69.57%-114.05%---
Depreciation & Amortization
0.70.280.030.030.02
EBIT
-14.68-23.09-41.48-22.93-33.6
EBIT Margin
-73.05%-115.46%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).